INTS CIK: 1567264

Intensity Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−8.00
FY22:
−7.55
FY23:
−8.32
FY24:
−16.6
FY25:
−12.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.88
FY22:
−7.50
FY23:
−7.97
FY24:
−16.3
FY25:
−12.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.90
FY22:
−7.58
FY23:
−10.5
FY24:
−16.3
FY25:
−11.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.90
FY22:
−7.58
FY23:
−10.5
FY24:
−16.3
FY25:
−11.6

All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data